What are you searching for?

Sign in
Exclusives

What People Were Reading in November 2022 on NutraceuticalsWorld.com

Our most-viewed stories in November included functional food trends as well as FDA action on NMN and heart disease claims.

...

By: Sean Moloughney

The U.S. FDA rejected a recent new dietary ingredient notification (NDIN) saying beta nicotinamide-mononucleotide (NMN) was first investigated as a new drug. The agency also sent warning letters to companies it said were making illegal claims pertaining to atherosclerosis, stroke, heart failure, and more.

Alongside regulatory updates, market trend analysis on functional foods/drinks, sports nutrition, and more captured the most clicks in November.


The Functional Chocolate Company Launches Painfree Chocolate
The new vegan chocolate bars are infused with turmeric, white willow, arnica, and hops extract.

DSM’s HMO Ingredient Receives Canadian Approval for Early Life Nutrition
The ingredient is the only HMO permitted in both infant and toddler formula products in the country.

Top Trends in the Global Functional Food and Drink Market for 2023
Consumers are eager for mood and mind benefits, and the healthy aging conversation becomes more important.

NDI Déjà vu: Another Ingredient Falls Victim to FDA’s Interpretation of Drug Preclusion Clause
Agency rejected an NDI notification from Kingdomway saying beta nicotinamide-mononucleotide was first investigated as a new drug.

Resistant Starch Associated with 60% Reduction in Upper GI Cancer Among Lynch Syndrome Patients
Individuals with Lynch Syndrome have significantly increased risk of developing many types of cancer.

Turmeric Extract Linked to Reductions in Post-Exercise Muscle Soreness
Supplementation with Nutriventia’s TurmXtra extract resulted in significant reductions in the pain intensity measured by visual analog scale.

Top Sports Nutrition Trends That Reach Athletes and Everyday Consumers
Next generation energy drinks, hydration, and mobility have broad appeal and room for growth.

Study Backs Efficacy of Cannabis-Derived BCP Ingredient
The first study on the new formulation of the sequisterpene was supported by Geocann.

FDA Warns Companies Allegedly Making Heart Disease Claims
The agency said seven companies with making claims pertaining to atherosclerosis, stroke, heart failure, and more.

Cognitive Health: Many Branches to a Complex Tree
There are plenty of evidence-based nutraceuticals to consider when developing formulations that offer specific cognitive health benefits.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics

Related Exclusives